Vor Biopharma

Vor BioPharma is an American clinical stage cell therapy company. It specializes in developing novel therapies for treating cancer. The company was incorporated in 2015 and is based in Cambridge, Massachusetts.
Vor Biopharma stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Vor Biopharma balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Vor Biopharma cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Vor Biopharma multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Vor Biopharma profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Vor Biopharma assets
Vor Biopharma cash flows

Vor Biopharma dividend policy

The company doesn't provide dividend

Vor Biopharma shares

TickerNameTypeNominal valueISINPrice
VOR:USVor BiopharmaCommon share-US9290331084$0.8639
Vor Biopharma news
13.05.2022
Vor Biopharma's GAAP loss for 3 months of 2022 was $22.737 million, up 65.7% from $13.723 million in the previous year.
Source: {source} pictogram ir.vorbio.com
Pictogram next
15.03.2022
Vor Biopharma's GAAP loss for 2021 was $68.899 million, up 59% from $43.337 million in the previous year.
Source: {source} pictogram ir.vorbio.com
Pictogram next
11.11.2021
Vor Biopharma's GAAP loss for 9M 2021 was $50.647 million, up 83% from $27.674 million in the previous year.
Source: {source} pictogram ir.vorbio.com
Pictogram next
10.08.2021
Vor Biopharma's GAAP loss for 6M 2021 was $32.093 million, doubling from $15.889 million in the previous year.
Source: {source} pictogram ir.vorbio.com
Pictogram next
All Vor Biopharma news
General information
Company nameVor Biopharma
Tags#biotechnology
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address100 Cambridgepark Drive Suite 400 Cambridge, MA 02140 United States
Mailing address100 Cambridgepark Drive Suite 400 Cambridge, MA 02140 United States
Websiteir.vorbio.com
Information disclosurewww.sec.gov